Murali Shankar Bhat
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Murali Shankar Bhat has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Anirudh Yadav
Department of Oral and Maxillofacial Surgery, A B Shetty Memorial Institute of Dental Sciences, Nitte (Deemed to be) University, India
1 shared publication Bhat Gayathri
1 shared publication- Chethana Bolanthakodi
Father Mullers Medical College, Mangaluru, Karnataka, India
1 shared publication - Devyani Bahl
Nitte Meenakshi Institute of Craniofacial Surgery, NITTE Deemed to be University, Mangalore, India
1 shared publication Hermann Sailer
Klinik Professor Sailer, Zurich, Switzerland
1 shared publication- Raghavendra Huchchannavar
NITTE Deemed Be Univ, KS Hegde Med Acad, Dept Community Med, Mangaluru, Karnataka, India
1 shared publication
Latest Publications
- Open Access
- 30 January 2026
- Published by Sri Lanka Journals Online in Sri Lankan Journal of Anaesthesiology
- Vol. 34 (1) , 94-103
Comparing the Effects of Intrathecal Buprenorphine versus Fentanyl as Adjuvant to Hyperbaric Ropivacaine in Lower Limb Surgeries
Background: Subarachnoid block is often the choice of anaesthesia for lower limb surgeries. Hyperbaric Ropivacaine, a newer commercially available local anaesthetic preparation, offers faster recovery and fewer cardiovascular effects than bupivacaine but has a shorter duration of action. To prolong anaesthesia and postoperative analgesia, opioids such as fentanyl and buprenor-phine are used as adjuvants to local anaesthetics.Aim: This study aimed to compare the efficacy and safety of intrathecal buprenorphine versus fen-tanyl as adjuvants to hyperbaric ropivacaine in lower limb surgeries.Material and Methods: A prospective, double-blinded, randomised controlled trial was carried out in 76 patients, aged 18–60 years, belonging to ASA I and II and scheduled for lower limb pro-cedures under subarachnoid block. Patients were randomly allocated into two groups: Group B was given 3 ml of 0.75% hyperbaric ropivacaine with 0.5 ml buprenorphine (150 mg), while Group F got the same dose of ropivacaine with 0.5 ml fentanyl (25 mg). Parameters assessed included onset,level, sensory and motor block duration, changes in the haemodynamics, postoperative analgesia, and side effects.Results: Group F showed a significantly faster onset (p=<0.001) and time to reach maximum sensory level (p=<0.001). However, Group B had a significantly prolonged duration of sensory block and analgesia (p=<0.001). Group B demonstrated better haemodynamic stability, with fewer episodes of hypotension and bradycardia, though not statistically significant. Onset of motor block was faster, but duration was shorter in Group B. Minor side effects like pruritus and urinary reten-tion were more frequent in Group B.Conclusion: Buprenorphine as an intrathecal adjuvant to hyperbaric ropivacaine provides superior postoperative analgesia, prolonged sensory block, and better hemodynamic stability than fentanyl, making it a preferable choice for lower limb surgeries.
- 30 January 2026
- Published by Sri Lanka Journals Online in Sri Lankan Journal of Anaesthesiology
- Vol. 34 (1) , 94-103
Open AccessComparing the Effects of Intrathecal Buprenorphine versus Fentanyl as Adjuvant to Hyperbaric Ropivacaine in Lower Limb Surgeries
Background: Subarachnoid block is often the choice of anaesthesia for lower limb surgeries. Hyperbaric Ropivacaine, a newer commercially available local anaesthetic preparation, offers faster recovery and fewer cardiovascular effects than bupivacaine but has a shorter duration of action. To prolong anaesthesia and postoperative analgesia, opioids such as fentanyl and buprenor-phine are used as adjuvants to local anaesthetics.Aim: This study aimed to compare the efficacy and safety of intrathecal buprenorphine versus fen-tanyl as adjuvants to hyperbaric ropivacaine in lower limb surgeries.Material and Methods: A prospective, double-blinded, randomised controlled trial was carried out in 76 patients, aged 18–60 years, belonging to ASA I and II and scheduled for lower limb pro-cedures under subarachnoid block. Patients were randomly allocated into two groups: Group B was given 3 ml of 0.75% hyperbaric ropivacaine with 0.5 ml buprenorphine (150 mg), while Group F got the same dose of ropivacaine with 0.5 ml fentanyl (25 mg). Parameters assessed included onset,level, sensory and motor block duration, changes in the haemodynamics, postoperative analgesia, and side effects.Results: Group F showed a significantly faster onset (p=<0.001) and time to reach maximum sensory level (p=<0.001). However, Group B had a significantly prolonged duration of sensory block and analgesia (p=<0.001). Group B demonstrated better haemodynamic stability, with fewer episodes of hypotension and bradycardia, though not statistically significant. Onset of motor block was faster, but duration was shorter in Group B. Minor side effects like pruritus and urinary reten-tion were more frequent in Group B.Conclusion: Buprenorphine as an intrathecal adjuvant to hyperbaric ropivacaine provides superior postoperative analgesia, prolonged sensory block, and better hemodynamic stability than fentanyl, making it a preferable choice for lower limb surgeries.
- Open Access
- 15 November 2024
- Published by IP Innovative Publication Pvt Ltd in Indian Journal of Clinical Anaesthesia
- Vol. 11 (4) , 453-457
Evaluation of the effect of cold normal saline as a carrier fluid in reducing propofol induced pain
: Pain or discomfort during intravenous injection is a common unwanted result of Propofol, and can lead to dissatisfaction. Various methods are used to reduce ‘pain on propofol injection’ (POPI), among which mixing lignocaine with propofol is commonly used. However mixing lignocaine destabilises propofol, leading to reduced anaesthetic properties of propofol, warranting the use of other methods. Cold temperatures reduce nerve conduction velocity resulting in decreased pain signal transmission and have vasoconstrictive properties which reduce local tissue irritation, potentially minimizing pain. To evaluate cold normal saline (at 4°C) as carrier fluid in reducing POPI compared to normal saline at room temperature, with a primary objective of assessing the incidence and severity of pain using a pain score and a secondary objective of assessing postoperative recall in both the groups. : A single-blinded prospective randomized controlled trial was conducted involving 76 patients undergoing general anaesthesia for elective surgeries. The patients were randomly assigned to two groups: Group C received cold saline (at 4°C) and Group R received room temperature saline as carrier fluids during propofol administration. Pain during injection was recorded using pain score, Heart rate changes before and after propofol administration, and Postoperative recall of injection pain was assessed.: The incidence of pain was significantly lower in Group C (52.6%) compared to Group R (81.57%) (p=0.007). Group R had a higher severity of pain, with more patients experiencing moderate to severe pain. Group R also showed an increase in heart rate (3.46%) compared to Group C (0.27%) (p=0.027). Postoperative recall of injection pain was more frequent in Group R than in Group C. Cold normal saline as a carrier fluid (at 4C) effectively reduces pain associated with propofol injection. This technique helps to enhance patient comfort and satisfaction, making it a valuable addition to clinical practice.
- 15 November 2024
- Published by IP Innovative Publication Pvt Ltd in Indian Journal of Clinical Anaesthesia
- Vol. 11 (4) , 453-457
Open AccessEvaluation of the effect of cold normal saline as a carrier fluid in reducing propofol induced pain
: Pain or discomfort during intravenous injection is a common unwanted result of Propofol, and can lead to dissatisfaction. Various methods are used to reduce ‘pain on propofol injection’ (POPI), among which mixing lignocaine with propofol is commonly used. However mixing lignocaine destabilises propofol, leading to reduced anaesthetic properties of propofol, warranting the use of other methods. Cold temperatures reduce nerve conduction velocity resulting in decreased pain signal transmission and have vasoconstrictive properties which reduce local tissue irritation, potentially minimizing pain. To evaluate cold normal saline (at 4°C) as carrier fluid in reducing POPI compared to normal saline at room temperature, with a primary objective of assessing the incidence and severity of pain using a pain score and a secondary objective of assessing postoperative recall in both the groups. : A single-blinded prospective randomized controlled trial was conducted involving 76 patients undergoing general anaesthesia for elective surgeries. The patients were randomly assigned to two groups: Group C received cold saline (at 4°C) and Group R received room temperature saline as carrier fluids during propofol administration. Pain during injection was recorded using pain score, Heart rate changes before and after propofol administration, and Postoperative recall of injection pain was assessed.: The incidence of pain was significantly lower in Group C (52.6%) compared to Group R (81.57%) (p=0.007). Group R had a higher severity of pain, with more patients experiencing moderate to severe pain. Group R also showed an increase in heart rate (3.46%) compared to Group C (0.27%) (p=0.027). Postoperative recall of injection pain was more frequent in Group R than in Group C. Cold normal saline as a carrier fluid (at 4C) effectively reduces pain associated with propofol injection. This technique helps to enhance patient comfort and satisfaction, making it a valuable addition to clinical practice.
- 11 June 2022
- Published by Elsevier in Journal of Cranio-Maxillofacial Surgery
- Vol. 50 (7) , 569-575
Efficacy of I- gel™ for airway management of neonates with Pierre Robin sequence undergoing glossopexy: A prospective study
- 11 June 2022
- Published by Elsevier in Journal of Cranio-Maxillofacial Surgery
- Vol. 50 (7) , 569-575
Efficacy of I- gel™ for airway management of neonates with Pierre Robin sequence undergoing glossopexy: A prospective study